UBALD1

Across TCGA pan-cancer cohorts, UBALD1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated UBALD1 data layer compared with 21 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher UBALD1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UBALD1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PDAC show a favorable association.

HNSC, PDAC, and UCEC are the cancer types where UBALD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	IV	0.987	0.736	.035	4	view →
PDAC	DFS	Quartile	III,IV	0.783	0.145	.024	4	view →
UCEC	OS	Median	III,IV	0.554	0.884	.045	4	view →
LUAD	OS	Quartile	II,III,IV	1.000	0.429	.017	2	view →
LSCC	DFS	Tertile	All	0.509	1.000	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

UBALD1–HNSC (OS)

Open the HNSC breakdown →